GDRX

2.24

1.36% 0.03

Dopo l'orario di chiusura: 2.24

Goodrx Holdings Inc (GDRX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché GDRX Giù? Forum Previsione

Precedente Chiudi:

$2.21

Aprire:

$2.2

Volume 24 ore:

1.35M

Relative Volume:

0.45

Capitalizzazione di mercato:

$767.37M

Reddito:

$796.85M

Utile/perdita netta:

$30.44M

Rapporto P/E:

26.60

EPS:

0.0842

Flusso di cassa netto:

$93.88M

1 W Prestazione:

-1.75%

1M Prestazione:

+2.75%

6M Prestazione:

-46.54%

1 anno Prestazione:

-49.89%

Intervallo 1D:

$2.18

$2.26

Intervallo di 1 settimana:

$2.18

$2.455

Portata 52W:

$1.77

$5.8099

Goodrx Holdings Inc Stock (GDRX) Company Profile

Nome

Goodrx Holdings Inc

Settore

Healthcare (1116)

Industria

Health Information Services (50)

Telefono

(855) 268-2822

Indirizzo

2701 OLYMPIC BOULEVARD, SANTA MONICA

Dipendente

697

Cinguettio

Prossima data di guadagno

2024-11-07

Ultimi documenti SEC

GDRX's Discussions on Twitter

Compare GDRX vs VEEV, TEM, BTSG, HQY, WAY

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
GDRX Goodrx Holdings Inc	2.24	767.37M	796.85M	30.44M	93.88M	0.0842
VEEV Veeva Systems Inc	178.88	29.40B	3.20B	908.91M	1.42B	5.4155
TEM Tempus Ai Inc	49.98	8.94B	1.27B	-245.03M	-245.36M	-1.4071
BTSG Brightspring Health Services Inc	38.31	7.36B	12.91B	104.80M	394.69M	0.8769
HQY Healthequity Inc	77.81	6.65B	1.15B	96.70M	-161.99M	1.09
WAY Waystar Holding Corp	24.16	4.63B	1.10B	112.09M	283.19M	0.6096

Goodrx Holdings Inc Stock (GDRX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-02-27	Downgrade	JP Morgan	Overweight → Neutral
2026-01-22	Downgrade	Jefferies	Buy → Hold
2025-12-09	Iniziato	Barclays	Underweight
2025-08-11	Downgrade	Raymond James	Strong Buy → Outperform
2024-12-04	Iniziato	Mizuho	Neutral
2024-08-09	Aggiornamento	Raymond James	Outperform → Strong Buy
2024-05-23	Aggiornamento	RBC Capital Mkts	Sector Perform → Outperform
2024-05-16	Aggiornamento	Raymond James	Mkt Perform → Outperform
2024-04-10	Aggiornamento	KeyBanc Capital Markets	Sector Weight → Overweight
2024-03-25	Aggiornamento	Wells Fargo	Equal Weight → Overweight
2024-03-01	Aggiornamento	JP Morgan	Neutral → Overweight
2024-02-26	Iniziato	Leerink Partners	Outperform
2024-01-02	Downgrade	BofA Securities	Buy → Underperform
2023-08-10	Aggiornamento	DA Davidson	Neutral → Buy
2023-07-31	Aggiornamento	TD Cowen	Market Perform → Outperform
2022-12-01	Iniziato	Citigroup	Buy
2022-11-04	Aggiornamento	JP Morgan	Underweight → Neutral
2022-09-16	Iniziato	KeyBanc Capital Markets	Sector Weight
2022-09-07	Iniziato	Truist	Hold
2022-08-12	Iniziato	DA Davidson	Neutral
2022-06-10	Downgrade	Goldman	Buy → Neutral
2022-06-06	Ripresa	BofA Securities	Buy
2022-06-01	Downgrade	Robert W. Baird	Outperform → Neutral
2022-05-10	Downgrade	Evercore ISI	Outperform → In-line
2022-05-10	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
2022-05-10	Downgrade	Raymond James	Outperform → Mkt Perform
2022-05-10	Downgrade	SVB Leerink	Outperform → Mkt Perform
2022-04-11	Iniziato	Wells Fargo	Equal Weight
2022-04-07	Iniziato	Guggenheim	Buy
2022-04-01	Ripresa	Credit Suisse	Neutral
2022-03-15	Aggiornamento	Robert W. Baird	Neutral → Outperform
2022-03-01	Reiterato	Barclays	Overweight
2022-03-01	Reiterato	BofA Securities	Neutral
2022-03-01	Downgrade	Cowen	Outperform → Market Perform
2022-03-01	Downgrade	Credit Suisse	Outperform → Neutral
2022-03-01	Reiterato	Evercore ISI	Outperform
2022-03-01	Reiterato	Goldman	Buy
2022-03-01	Reiterato	JP Morgan	Underweight
2022-03-01	Reiterato	RBC Capital Mkts	Outperform
2022-03-01	Reiterato	SVB Leerink	Outperform
2022-01-07	Iniziato	Goldman	Buy
2021-12-21	Iniziato	Stephens	Overweight
2021-12-02	Iniziato	Jefferies	Buy
2021-08-31	Aggiornamento	Barclays	Equal Weight → Overweight
2021-08-13	Aggiornamento	Raymond James	Mkt Perform → Outperform
2021-05-28	Iniziato	Robert W. Baird	Neutral
2021-04-06	Ripresa	Evercore ISI	Outperform
2021-01-25	Iniziato	Guggenheim	Buy
2020-11-19	Aggiornamento	RBC Capital Mkts	Sector Perform → Outperform
2020-11-18	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2020-10-19	Iniziato	Barclays	Equal Weight
2020-10-19	Iniziato	BofA Securities	Neutral
2020-10-19	Iniziato	Citigroup	Buy
2020-10-19	Iniziato	Cowen	Outperform
2020-10-19	Iniziato	Credit Suisse	Outperform
2020-10-19	Iniziato	Deutsche Bank	Hold
2020-10-19	Iniziato	Goldman	Neutral
2020-10-19	Iniziato	JP Morgan	Neutral
2020-10-19	Iniziato	Morgan Stanley	Overweight
2020-10-19	Iniziato	RBC Capital Mkts	Sector Perform
2020-10-19	Iniziato	SVB Leerink	Outperform
2020-10-19	Iniziato	UBS	Buy

Mostra tutto

Goodrx Holdings Inc Borsa (GDRX) Ultime notizie

Mar 14, 2026

Lakewood Capital Management LP Decreases Position in GoodRx Holdings, Inc. $GDRX - MarketBeat

Mar 14, 2026

Mar 11, 2026

Published on: 2026-03-12 03:47:43 - baoquankhu1.vn

Mar 11, 2026

GoodRx (NASDAQ:GDRX) Shares Down 6%Time to Sell? - MarketBeat

Mar 11, 2026

GoodRx Holdings, Inc. announced that consumers paying with cash through its platform can enjoy up to 85% discounts on medications at more than 70,000 pharmacies across the United States. - Bitget

Mar 11, 2026

GoodRx (GDRX) Partners with Viatris for Major Medication Discoun - GuruFocus

Mar 11, 2026

GoodRx offers up to 85% discount on Viatris drugs (GDRX) - Seeking Alpha

Mar 11, 2026

Lipitor and Viagra discounts: GoodRx deal cuts brand drugs to $0–$4 - Stock Titan

Mar 11, 2026

Mar 09, 2026

GoodRx (GDRX) CAO converts RSUs to stock and withholds shares for taxes - Stock Titan

Mar 09, 2026

GoodRx: Losing Relevance With Consumers (Downgrade) (NASDAQ:GDRX) - Seeking Alpha

Mar 09, 2026

Mar 08, 2026

GoodRx (GDRX) Q4 2025 Earnings Call Transcript - AOL.com

Mar 08, 2026

Mar 06, 2026

Aug Technicals: How does GoodRx Holdings Inc perform in inflationary periods2025 Investor Takeaways & Verified Momentum Stock Ideas - baoquankhu1.vn

Mar 06, 2026

Aug Reactions: Is GoodRx Holdings Inc showing insider buyingMarket Movement Recap & Short-Term High Return Ideas - baoquankhu1.vn

Mar 06, 2026

GoodRx awards discretionary cash bonus to chief accounting officer - Investing.com UK

Mar 06, 2026

GoodRx awards discretionary cash bonus to chief accounting officer By Investing.com - Investing.com South Africa

Mar 06, 2026

GoodRx Awards Performance-Based Bonus to Chief Accounting Officer - TipRanks

Mar 06, 2026

GoodRx approves $72,918 discretionary bonus for Chief Accounting Officer Romin Nabiey - TradingView

Mar 06, 2026

GoodRx (GDRX) Board approves $72,918 bonus for Chief Accounting Officer - Stock Titan

Mar 06, 2026

U.S. medical discount service provider GoodRx Holdings, Inc. recently announced the launch of an innovative subsidy program for self-insured employers. - Bitget

Mar 06, 2026

GoodRx to expand employer-sponsored access to Zepbound® Kwikpen® - marketscreener.com

Mar 06, 2026

Obesity drug Zepbound now offered to workers at $449 through GoodRx - Stock Titan

Mar 06, 2026

Mar 04, 2026

GDRX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Mar 04, 2026

GDRX: Wells Fargo Maintains Rating, Lowers Price Target by 50% | - GuruFocus

Mar 04, 2026

Wells Fargo & Company Has Lowered Expectations for GoodRx (NASDAQ:GDRX) Stock Price - MarketBeat

Mar 04, 2026

Mar 03, 2026

GoodRx Holdings (GDRX) Analyst Rating Update: Citigroup Lowers P - GuruFocus

Mar 03, 2026

Citigroup Lowers GoodRx (NASDAQ:GDRX) Price Target to $3.50 - MarketBeat

Mar 03, 2026